|
|
Vaccine Comparison
|
NYVAC-PRV- gII/ gp50 |
rORFV-PRV-gC/gD |
| Vaccine Information |
Vaccine Information |
- Vaccine Ontology ID: VO_0004778
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- GII
gene engineering:
- Type: Recombinant vector construction
- Description: A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 (Brockmeier and Mengeling, 1996).
- Detailed Gene Information: Click Here.
- gp50
gene engineering:
- Type: Recombinant vector construction
- Description: A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 (Brockmeier and Mengeling, 1996).
- Detailed Gene Information: Click Here.
- Vector: NYVAC vaccine vector
- Preparation: (Brockmeier and Mengeling, 1996) A NYVAC vaccinia vector containing genes for PRV gII and gp50 .
- Immunization Route: Intramuscular injection (i.m.)
|
- Vaccine Ontology ID: VO_0004770
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- Vector: ORF virus vaccine vector
- Preparation: Based on the attenuated ORFV strain D1701-V, recombinants were produced that express the glycoproteins gC (D1701-VrVgC) or gD (D1701-VrVgD) of the alphaherpesvirus of swine, pseudorabies virus (PRV) (Fischer et al., 2003).
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
References |
Brockmeier and Mengeling, 1996: Brockmeier SL, Mengeling WL. Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 1996; 60(4); 315-317. [PubMed: 8904669].
|
Fischer et al., 2003: Fischer T, Planz O, Stitz L, Rziha HJ. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. Journal of virology. 2003; 77(17); 9312-9323. [PubMed: 12915547].
|
|
